Procter & Gamble Health Limited Cash Flow Conversion Efficiency

Latest as of September 2025: 0.278x

Procter & Gamble Health Limited cash flow conversion efficiency. Based on the latest financial reports, Procter & Gamble Health Limited (PGHL) has a cash flow conversion efficiency ratio of 0.278x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs1.72 Billion ≈ $18.63 Million USD) by net assets (Rs6.20 Billion ≈ $67.02 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Procter & Gamble Health Limited (2003–2024)

Cash flow conversion efficiency of Procter & Gamble Health Limited from 2003 to 2024. This chart illustrates how Procter & Gamble Health Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Procter & Gamble Health Limited stock quote for real-time trading data and today's change.

Procter & Gamble Health Limited Cash Flow Conversion Ratio Explained

Procter & Gamble Health Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Procter & Gamble Health Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Procter & Gamble Health Limited ranked by their cash flow conversion efficiency. Also see how much is Procter & Gamble Health Limited worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Prosegur Cash S.A MC:CASH	0.233x
Telia Lietuva AB F:ZWS	0.108x
SBFC Finance Limited NSE:SBFC	-0.243x
ARIZONA SONORAN COPPER F:H6F	-0.004x
Sunwave Communications Co Ltd SHE:002115	-0.059x
Huangshan Novel Co Ltd SHE:002014	0.117x
AMC Entertainment Holdings Inc NYSE:AMC	0.067x
Dalian Bio-Chem Co Ltd SHG:603360	0.098x

Annual Cash Flow Conversion Efficiency for Procter & Gamble Health Limited (2003–2024)

The table below shows the annual cash flow conversion efficiency of Procter & Gamble Health Limited from 2003 to 2024. Review PGHL cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Rs5.37 Billion ≈ $58.07 Million	Rs1.76 Billion ≈ $19.02 Million	0.327x	-22.79%
2023-12-31	Rs5.38 Billion ≈ $58.21 Million	Rs2.28 Billion ≈ $24.69 Million	0.424x	+34.94%
2022-12-31	Rs7.51 Billion ≈ $81.21 Million	Rs2.36 Billion ≈ $25.52 Million	0.314x	+14.30%
2021-12-31	Rs6.16 Billion ≈ $66.67 Million	Rs1.70 Billion ≈ $18.33 Million	0.275x	-21.74%
2020-12-31	Rs7.04 Billion ≈ $76.10 Million	Rs2.47 Billion ≈ $26.74 Million	0.351x	+7.61%
2019-12-31	Rs9.06 Billion ≈ $98.02 Million	Rs2.96 Billion ≈ $32.00 Million	0.327x	+485.69%
2018-12-31	Rs15.40 Billion ≈ $166.56 Million	Rs-1.30 Billion ≈ $-14.10 Million	-0.085x	-215.68%
2017-12-31	Rs7.33 Billion ≈ $79.30 Million	Rs536.60 Million ≈ $5.80 Million	0.073x	-55.87%
2016-12-31	Rs6.45 Billion ≈ $69.80 Million	Rs1.07 Billion ≈ $11.58 Million	0.166x	+17.26%
2015-12-31	Rs5.92 Billion ≈ $63.97 Million	Rs836.60 Million ≈ $9.05 Million	0.141x	+1483.68%
2014-12-31	Rs5.54 Billion ≈ $59.95 Million	Rs49.50 Million ≈ $535.32K	0.009x	+937.95%
2013-12-31	Rs5.23 Billion ≈ $56.56 Million	Rs4.50 Million ≈ $48.67K	0.001x	-99.23%
2012-12-31	Rs4.84 Billion ≈ $52.31 Million	Rs542.60 Million ≈ $5.87 Million	0.112x	+280.13%
2011-12-31	Rs4.10 Billion ≈ $44.35 Million	Rs-255.40 Million ≈ $-2.76 Million	-0.062x	-132.70%
2010-12-31	Rs3.46 Billion ≈ $37.46 Million	Rs659.70 Million ≈ $7.13 Million	0.190x	+113.20%
2009-12-31	Rs4.67 Billion ≈ $50.54 Million	Rs417.40 Million ≈ $4.51 Million	0.089x	+936.50%
2008-12-31	Rs4.51 Billion ≈ $48.82 Million	Rs38.90 Million ≈ $420.69K	0.009x	-90.44%
2007-12-31	Rs4.23 Billion ≈ $45.74 Million	Rs381.10 Million ≈ $4.12 Million	0.090x	-56.34%
2006-12-31	Rs3.93 Billion ≈ $42.50 Million	Rs811.20 Million ≈ $8.77 Million	0.206x	-20.21%
2005-12-31	Rs2.98 Billion ≈ $32.24 Million	Rs771.20 Million ≈ $8.34 Million	0.259x	-18.21%
2004-12-31	Rs2.48 Billion ≈ $26.84 Million	Rs784.90 Million ≈ $8.49 Million	0.316x	-14.07%
2003-12-31	Rs1.96 Billion ≈ $21.22 Million	Rs722.30 Million ≈ $7.81 Million	0.368x	--

About Procter & Gamble Health Limited

NSE:PGHL India Drug Manufacturers - Specialty & Generic

Market Cap

$1.05 Billion

Rs96.74 Billion INR

Market Cap Rank

#8388 Global

#414 in India

Share Price

Rs5828.00

Change (1 day)

+2.78%

52-Week Range

Rs4778.60 - Rs6918.50

All Time High

Rs6918.50